These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34334379)

  • 1. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
    Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
    Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
    Gao F; Wang Y; Li H; Yin J
    Technol Health Care; 2024; 32(5):3083-3095. PubMed ID: 38848201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
    Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
    Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
    Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
    Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
    Zhao S; Yao D; Chen J; Ding N
    Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
    Liu P; Xin F; Ma CF
    Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
    Luo Q; Wang H; Li J
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
    Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
    Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer.
    Wei H; Wen-Ming C; Jun-Bo J
    J Int Med Res; 2017 Jun; 45(3):1054-1060. PubMed ID: 28534701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
    Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
    Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
    Rao X; Jiang J; Wang Y; Ma X; Liu S
    Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.
    Shao MX; Qu AZ; Wang YQ; Zhong YY
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6583-6588. PubMed ID: 32633346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
    Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
    BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer.
    You W; Wang Y; Zheng J
    Reprod Sci; 2015 Aug; 22(8):1037-41. PubMed ID: 25701838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
    Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
    Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia.
    Xin F; Liu P; Ma CF
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4846-4851. PubMed ID: 27981553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer.
    Yin S; Yang M; Li X; Zhang K; Tian J; Luo C; Bai R; Lu Y; Wang M
    J Cell Biochem; 2020 Jan; 121(1):596-608. PubMed ID: 31407404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
    Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
    Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.